ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2778

Alcohol Consumption as a Predictor of the Progression of Spinal Structural Damage in Axial Spondyloarthritis: Data from the Catholic Axial Spondyloarthritis COhort (CASCO)

Hong Ki Min1, Seung-Ki Kwok 2 and Sang-Heon Lee 1, 1Konkuk university medical center, Seoul, Republic of Korea, 2Division of Rheumatology, Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: alcohol use, axial spondyloarthritis, modified stoke ankylosing spondylitis spinal score (MSASSS) and syndesmophyte

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, November 12, 2019

Title: 5T094: Spondyloarthritis Including Psoriatic Arthritis – Clinical V: Axial Spondyloarthritis Clinical Studies (2774–2779)

Session Type: ACR Abstract Session

Session Time: 2:30PM-4:00PM

Background/Purpose: The purpose of the present study was to demonstrate the predicting factors of spinal structural damage in axial spondyloarthritis (axSpA) in a prospective cohort study.

Methods: AxSpA patients were enrolled from a single tertiary hospital in a prospective cohort. Baseline data were collected, and 2 year follow-up radiographic data were collected. We analyzed the progression of spinal structural damage in 278 axSpA patients and grouped them into alcohol drinkers and non-drinkers. Baseline and follow up characteristics were compared between the two groups. Univariable and multivariable logistic regression analysis were performed to reveal predictors of spinal structural damage.

Results: Change of modified Stoke Ankylosing Spondylitis Spinal Score (mSASSS) and syndesmophyte count over the 2 year period were more prominent in the alcohol drinker group than in the non-drinker group (2.7 ± 3.6 vs 1.5 ± 2.8, P=0.007, 0.9 ± 1.3 vs 0.4 ± 1.2, P=0.003). The alcohol drinker group showed more frequent significant mSASSS changes (≥2 units for 2 years follow up) and new syndesmophyte/progression of pre-existing syndesmophyte than the non-drinker group (60.7% vs 29.2%, P< 0.001, 51.5% vs 26.4%, P< 0.001, respectively). On univariable and multivariable regression analysis, drinking alcohol showed a significant relationship with the progression of spinal structural damage for both mSASSS and syndesmophyte progression.

Conclusion: The present study showed that alcohol consumption could predict progression of spinal structural damage in axSpA. This is meaningful because drinking alcohol is a modifiable behavior and education on alcohol consumption could aid in attenuating spinal structural damage in axSpA.


Table 2 PDF


Disclosure: H. Min, None; S. Kwok, None; S. Lee, None.

To cite this abstract in AMA style:

Min H, Kwok S, Lee S. Alcohol Consumption as a Predictor of the Progression of Spinal Structural Damage in Axial Spondyloarthritis: Data from the Catholic Axial Spondyloarthritis COhort (CASCO) [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/alcohol-consumption-as-a-predictor-of-the-progression-of-spinal-structural-damage-in-axial-spondyloarthritis-data-from-the-catholic-axial-spondyloarthritis-cohort-casco/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/alcohol-consumption-as-a-predictor-of-the-progression-of-spinal-structural-damage-in-axial-spondyloarthritis-data-from-the-catholic-axial-spondyloarthritis-cohort-casco/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology